Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Helsinki
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

ORNBV:FH

28.8000 EUR 0.1400 0.48%

As of 04:15:29 ET on 03/04/2015.

Snapshot for Orion Oyj (ORNBV)

Open: 28.9000 Day's Range: 28.7000 - 28.9400 Volume: 18,650
Previous Close: 28.9400 52wk Range: 21.0600 - 31.3300 1-Yr Rtn: +23.97%

Stock Chart for ORNBV

No chart data available.
  • ORNBV:FH 28.7900
  • 1D
  • 1M
  • 1Y
28.9400
Interactive ORNBV Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ORNBV

Current P/E Ratio (ttm) 19.4161
Estimated P/E(12/2015) 22.9603
Relative P/E vs. HEXP 0.8804
Earnings Per Share (EUR) (ttm) 1.4900
Est. EPS (EUR) (12/2015) 1.2600
Est. PEG Ratio -
Market Cap (M EUR) 4,092.25
Shares Outstanding (M) 100.84
30 Day Average Volume 298,728
Price/Book (mrq) 7.8418
Price/Sale (ttm) 3.9763
Dividend Indicated Gross Yield 4.49%
Cash Dividend (EUR) 1.3000
Dividend Ex-Date 03/25/2015
5 Year Dividend Growth 5.64%
Next Earnings Announcement 04/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ORNBV

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for ORNBV

Orion Oyj develops and manufactures pharmaceuticals and diagnostic kits. The Company produces hormone therapies and drugs to treat central nervous system disorders, cardiovascular diseases and urological disorders, and in vitro diagnostic kits used in doctor's offices and small laboratories.

Hannu SyrjaenenChairmanJukka YlppoVice Chairman
Timo LappalainenPresident/CEOJari KarlsonChief Financial Officer
More Company Profile & Key Executives for ORNBV

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil